Skip to main content
. 2013 Sep 27;48(4):362–367. doi: 10.1016/j.rboe.2013.01.001

Table 1.

Complications.

Group 1 Group 2
Dermatitis 02 04
Bleeding 02 01
Residual edema 03 02